CORD LLC
CORD, LLC Completes 1 Year Follow-Up on Subjects From the Model SC9 Intraocular Lens FDA Clinical Trial
This important milestone enables the company to file a Premarket Approval application to secure FDA approval for the commercial distribution of the Model SC9 in the United States.
